利通科技(832225) - 投资者关系活动记录表

Group 1: Investor Relations Activity Overview - The investor relations activity was an earnings briefing held on April 29, 2025, via the "Investor Relations Interactive Platform" [3] - Key attendees included the Chairman and General Manager, Mr. Zhao Hongliang, and the Secretary of the Board, Mr. He Jun [3] Group 2: Company Performance and Strategy - The company has a low debt-to-asset ratio and sufficient production capacity to meet market demand without immediate external financing needs [4] - The company is exploring flexible marketing strategies for its high-value ultra-high pressure sterilization equipment, including installment payments and leasing options [5] Group 3: Product Development and Market Position - The company is actively working on replacing imported products in the shield tunneling machine market and is narrowing performance gaps with international competitors [6] - In 2024, the company completed trials for 43 types of nuclear power hoses, with plans for domestic production to replace imports [7] Group 4: Sales and Revenue Insights - In Q1 2025, sales of hydraulic hoses and assemblies increased significantly due to a recovery in the domestic engineering machinery market, with major clients including SANY and XCMG [8] - The acid fracturing hose business has seen record sales in Q1 2025, continuing the positive trend from Q4 2024 [9] Group 5: Financial Performance Analysis - The company's revenue for 2024 remained stable compared to 2023, but net profit declined by approximately 20% due to a decrease in high-margin product sales [10] - The company has become a primary supplier for China National Petroleum Corporation, with ongoing efforts to expand the domestic market for acid fracturing hoses [11] Group 6: Product Specifications and Manufacturing - The 300L ultra-high pressure sterilization equipment is fully domestically produced, with no reliance on imported key components [12]